1. Home
  2. ICD-10-PCS
  3. XXE97U7
  4. Share
  5. Feedback

ICD-10-PCS Code XXE97U7

Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7
“Measurement of Nasophrn Fluid SARS-CoV-2 PCR, New Tech 7” for short

XXE97U7 is a valid billable ICD-10 procedure code for Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7. It is found in the 2024 version of the ICD-10 Procedure Coding System (PCS) and can be used in all HIPAA-covered transactions from Oct 01, 2023 - Sep 30, 2024.

Measurement involves:
Determining the level of a physiological or physical function at a point in time.

Via Natural or Artificial Opening approach involves:
Entry of instrumentation through a natural or artificial external opening to reach the site of the procedure

ICD-10-PCS code structure for XXE97U7 — See Table View

1: Section X New Technology
2: Body System X Physiological Systems
3: Root Operation E Measurement
4: Body Part 9 Nose
5: Approach 7 Via Natural or Artificial Opening
6: Device U Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction
7: Qualifier 7 New Technology Group 7

See also

  • The ICD-10-PCS Index of common procedure terms.
  • New Technology terms in the ICD-10-PCS Definitions table. These definitions may also provide additional explanation and/or examples within this section.
  • The ICD-10-PCS Device Aggregation Table containing entries that correlate a specific ICD-10-PCS device value with a general device value to be used in tables containing only general device values.